Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  

What's New at The Body

HIV/AIDS News You Can Use

December 12, 2001

The Body Covers ICAAC

An important AIDS conference begins this weekend in Chicago, and The Body will be the place to go for top-notch coverage of the entire event. Ten of the U.S.' most outstanding HIV specialists will bring you exclusive, next-day coverage of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, which will run from Dec. 16 to Dec. 19, 2001.

Possible Dangers of Garlic Supplements

Researchers have found garlic supplements can cause a potentially harmful side effect when combined with the anti-HIV drug saquinavir. They caution that both doctors and patients should be wary of using garlic supplements during HIV therapy.

Staying Adherent to Your Drug Regimen

Sticking to an HIV-treatment regimen isn't easy for even the most organized person, but there are plenty of ways to increase your odds of adherence before and during HIV therapy. This helpful new guide on adherence from Project Inform will tell you how.

What's This Tenofovir I've Heard So Much About?

Everything you wanted to know about tenofovir -- including how to use it, where to get it, notable side effects and information on resistance -- from Project Inform.

The Latest on the HIV-Treatment Front

Looking for the newest information available on HIV treatment? Project Inform's latest update will fill you in.

HIV May Make T Cells Age Faster

New findings are challenging the long-held view that HIV lowers a person's CD4 count by preventing T cells from reproducing. Instead, these findings suggest that HIV causes T cells to reproduce more rapidly than usual -- thus causing them to die far more quickly.

Holiday Travel Tips for the HIV Positive

Traveling for the holidays? Check out The Body's collection of articles on travel specific to HIV-positive people.

Connect with Others at The Body's Forums

Meet others who share your interests and HIV concerns at The Body's busy community center!

Adefovir: Bad for HIV, Good for Hep B

Although adefovir dipovoxil was studied -- and rejected -- as a possible anti-HIV drug, it may be a promising treatment for hepatitis-B sufferers. Read more in the latest fact sheet from Project Inform.

How Many Children Has HIV Treatment Saved?

A study of over a thousand HIV-infected children from 1996 through 1999 provides more definitive information on the benefits of improved treatment. AIDS Treatment News reports on a recent journal article -- as well as an accompanying editorial -- that discusses the risks of treatment in children, prevention of maternal transmission of HIV, and the status of efforts to prevent and treat pediatric AIDS in developing countries.

Preventing a Catastrophe in Nigeria

Today, even if we take the grossly underestimated figures used by the Nigerian government, the country has a whopping 2.6 million HIV/AIDS cases. But it's not too late to start saving lives. Click here for the details.

Two Resistance Tests Are Better Than One

The first resistance testing that combines both phenotypic and genotypic testing is intended especially for difficult treatment decisions. John James explains how this is used, in AIDS Treatment News.

Drug Resistance: Predicting the Future

More details are now available on last week's news that it may be possible to predict an anti-HIV regimen's eventual failure after only six days of treatment. Read the latest in-depth information in AIDS Treatment News.

After 9/11, Rethinking AIDS Research

Gregg Gonsalves offers his opinion on how priorities should be re-evaluated for basic and applied AIDS research in the post-Sept. 11 era.

A Look Back at the IAS Conference

GMHC's Treatment Issues weighs in on this past summer's International AIDS Society conference.

Web Highlights
A Selection of the Top HIV/AIDS Stories from Across the Internet

HIV Patients Get Fresh Hopes for Donor Organs
From The New York Times (December 11, 2001) (free registration required)

Predictors of Outcomes in Patients with HIV Infection Treated with Indinavir, Zidovudine, and Lamivudine
From Annals of Internal Medicine (December 4, 2001)

Where Epidemiology Meets Biology: Primary HIV Infection and Sexual Transmission
By Jim Koopman, M.D., M.P.H. and Christopher D. Pilcher, M.D.
From The PRN Notebook (December 2001)

HIV Viral Load Response to Antiretroviral Therapy According to the Baseline CD4 Cell Count and Viral Load
From Journal of the American Medical Association (November 28, 2001)

Global HIV/AIDS Revisited
By David Satcher, M.D., Ph.D.
From Journal of the American Medical Association (November 28, 2001)

Initiating Antiretroviral Therapy During HIV Infection
Editorial by Roger J. Pomerantz, M.D.
From Journal of the American Medical Association (November 28, 2001)

  
Previous Update | Next Update
Back to The Body's HIV/AIDS News Updates main page